FAM117A expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 1.228640E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
6.246200E-01
Normal-vs-Stage2
4.296400E-01
Normal-vs-Stage3
3.896600E-01
Normal-vs-Stage4
4.408400E-01
Stage1-vs-Stage2
2.408400E-01
Stage1-vs-Stage3
2.398400E-01
Stage1-vs-Stage4
2.704000E-01
Stage2-vs-Stage3
6.358000E-01
Stage2-vs-Stage4
9.249200E-01
Stage3-vs-Stage4
4.889000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
1.626220E-01
Normal-vs-AfricanAmerican
4.065600E-01
Normal-vs-Asian
3.668600E-01
Caucasian-vs-AfricanAmerican
9.715800E-02
Caucasian-vs-Asian
1.460050E-03
AfricanAmerican-vs-Asian
3.432600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
4.741200E-01
Normal-vs-Female
2.061600E-01
Male-vs-Female
6.911600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
8.949400E-01
Normal-vs-Age(41-60Yrs)
3.704200E-01
Normal-vs-Age(61-80Yrs)
4.504200E-01
Normal-vs-Age(81-100Yrs)
4.563800E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
4.982600E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
4.555200E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
4.630400E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
2.633000E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
3.071200E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
8.962600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
4.067200E-01
Normal-vs-Daily Drinker
3.128600E-01
Normal-vs-Weekly Drinker
3.998600E-01
Normal-vs-Occasional Drinker
5.023400E-01
Normal-vs-Social Drinker
7.766200E-01
Non Drinker-vs-Daily Drinker
2.878400E-01
Non Drinker-vs-Weekly Drinker
8.568600E-01
Non Drinker-vs-Occasional Drinker
1.633210E-01
Non Drinker-vs-Social Drinker
2.712000E-01
Daily Drinker-vs-Weekly Drinker
2.588200E-01
Daily Drinker-vs-Occasional Drinker
8.587000E-01
Daily Drinker-vs-Social Drinker
5.478600E-01
Weekly Drinker-vs-Occasional Drinker
1.378020E-01
Weekly Drinker-vs-Social Drinker
2.585200E-01
Occasional Drinker-vs-Social Drinker
4.745600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
3.985200E-01
Normal-vs-Grade 2
9.721800E-02
Normal-vs-Grade 3
3.804200E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
4.986200E-02
Grade 1-vs-Grade 3
3.190000E-02
Grade 1-vs-Grade 4
3.985200E-01
Grade 2-vs-Grade 3
1.998790E-01
Grade 2-vs-Grade 4
9.721800E-02
Grade 3-vs-Grade 4
3.804200E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
4.684800E-01
Normal-vs-NonDiabetic
2.184600E-01
Diabetic-vs-NonDiabetic
6.650600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
3.868000E-01
Normal-vs-NoPancreatitis
1.549350E-01
Pancreatitis-vs-NoPancreatitis
4.215800E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
4.630600E-01
Normal-vs-N1
4.309200E-01
N0-vs-N1
1.289980E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
3.946600E-01
Normal-vs-TP53-NonMutant
6.109400E-01
TP53-Mutant-vs-TP53-NonMutant
8.183600E-04
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
